Realistic microscopic illustration of cancer and epithelial cells sensing distant tissue features via collagen matrix, highlighting research on extended cellular reach and metastasis.
Realistic microscopic illustration of cancer and epithelial cells sensing distant tissue features via collagen matrix, highlighting research on extended cellular reach and metastasis.
Изображение, созданное ИИ

Cells can sense 10 times farther than expected, a finding that may shed light on cancer spread

Изображение, созданное ИИ
Проверено фактами

Engineers at Washington University in St. Louis report that while single abnormal cells can mechanically probe roughly 10 microns beyond what they directly touch, groups of epithelial cells can combine forces through collagen to sense features more than 100 microns away—an effect the researchers say could help explain how cancer cells navigate tissue.

Researchers at Washington University in St. Louis say they have identified a form of long-range mechanical sensing that allows cells to detect features far beyond the surfaces they are physically attached to.

The study—led by Amit Pathak, a professor of mechanical engineering and materials science at the university’s McKelvey School of Engineering, with PhD student Hongsheng Yu as a co-author—was published in Proceedings of the National Academy of Sciences in 2025.

How far cells can “feel”

According to the researchers, prior work from the group showed that single abnormal cells with “high front-rear polarity,” a trait associated with migrating cells, can detect physical cues up to about 10 microns beyond their immediate point of attachment. They do this by pulling on and deforming surrounding collagen fibers in the extracellular matrix, which can transmit information about what lies ahead.

In the new work, the team reports that epithelial cells—cells that line surfaces of many tissues—can extend that sensing range dramatically when they move and deform collagen as a collective. Using a collagen–polyacrylamide double-layer hydrogel system, the researchers found that epithelial cell collectives could mechanosense an underlying “basal” substrate at depths greater than 100 microns, as measured through cell clustering behavior and collagen deformation.

“Because it’s a collective of cells, they are generating higher forces,” Pathak said in a university release describing the research.

Modeling suggests a two-stage process

The researchers also used computational modeling to examine how collective forces translate into long-range sensing. The model described the behavior as unfolding in two broad stages: an initial phase of cell clustering accompanied by dynamic collagen deformation, followed by a phase of cell migration and dispersal.

In the experiments described in the paper’s abstract, stiffer underlying substrates were associated with higher collagen deformation and stiffening and with reduced dispersal of epithelial clusters.

Why it matters for cancer research

In a summary released by the university, the researchers suggest that the ability to detect what lies ahead could help cancer cells escape a tumor and navigate surrounding tissue. The release argues that understanding how sensing range is controlled could point to strategies aimed at disrupting a cancer cell’s ability to “feel” its path, potentially limiting migration.

The work was supported by the National Institutes of Health under grant R35GM128764 and the National Science Foundation’s Civil, Mechanical and Manufacturing Innovation program under grant 2209684.

Связанные статьи

Illustration of scientists mapping proteins enabling carcinomas to change identity in pancreatic and lung cancers, revealing potential therapy targets.
Изображение, созданное ИИ

Scientists map proteins that let carcinomas change identity

Сообщено ИИ Изображение, созданное ИИ Проверено фактами

Researchers at Cold Spring Harbor Laboratory have identified key proteins and protein complexes that help certain carcinomas shift their cellular identity and potentially evade treatment. Two new studies, focusing on pancreatic cancer and tuft cell lung cancer, highlight molecular structures that could become targets for more precise and selective therapies.

Researchers at Oregon Health & Science University have identified hidden fluid flows inside cells that rapidly transport proteins to the leading edge, challenging traditional views of cellular movement. The discovery, made during a classroom experiment, could explain why some cancer cells spread aggressively. The findings appear in Nature Communications.

Сообщено ИИ

Scientists have developed an ultra-sensitive Raman imaging system that identifies cancerous tissue by detecting faint light signals from nanoparticles bound to tumor markers. This technology, far more sensitive than current tools, could accelerate cancer screening and enable earlier detection. Led by researchers at Michigan State University, the system promises to bring advanced imaging into clinical practice.

Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg have created an AI-powered tool named MAGIC to identify cells with early chromosomal abnormalities linked to cancer. This system automates the detection of micronuclei, small DNA-containing structures that signal potential cancer development. The technology verifies a theory proposed over a century ago by Theodor Boveri.

Сообщено ИИ Проверено фактами

A team led by Nobel laureate Ardem Patapoutian at Scripps Research, working with collaborators at the Allen Institute, has secured a five-year, $14.2 million NIH Director’s Transformative Research Award to build what they describe as the first atlas of interoception—the internal sensory system that helps keep breathing, blood pressure and digestion in balance. ([eurekalert.org](https://www.eurekalert.org/news-releases/1101449?utm_source=openai))

Researchers at the University of Waterloo have developed engineered bacteria designed to invade and eat solid tumors from the inside out. The approach uses microbes that thrive in oxygen-free environments, targeting the low-oxygen cores of tumors. A genetic modification allows the bacteria to survive near oxygenated edges, controlled by a quorum-sensing mechanism.

Сообщено ИИ

Researchers from MIT and Stanford University have developed multifunctional molecules called AbLecs to block sugar-based immune checkpoints on cancer cells. This approach aims to enhance immunotherapy by allowing immune cells to better target tumors. Early tests in cells and mice show promising results in boosting anti-tumor responses.

 

 

 

Этот сайт использует куки

Мы используем куки для анализа, чтобы улучшить наш сайт. Прочитайте нашу политику конфиденциальности для дополнительной информации.
Отклонить